Mineralys Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Mineralys Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Mineralys Therapeutics Inc
Rating: 1.61966675
Author: Trendlyne DVM scores

about

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...

14.49 -0.15 (-1.02%)

75.85% Gain from 52W Low

442.5K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.2 / 100

Technically Neutral

57.6 / 100

No estimates available

Mineralys Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mineralys Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...

75.85% Gain from 52W Low

SWOT Analysis

Mineralys Therapeutics Inc Live Price Chart